| Current concepts and treatments of schizophrenia P Stępnicki, M Kondej, AA Kaczor Molecules 23 (8), 2087, 2018 | 510 | 2018 |
| Multi-target approach for drug discovery against schizophrenia M Kondej, P Stępnicki, AA Kaczor International journal of molecular sciences 19 (10), 3105, 2018 | 98 | 2018 |
| Overcoming Depression with 5-HT2A Receptor Ligands A Zięba, P Stępnicki, D Matosiuk, AA Kaczor International Journal of Molecular Sciences 23 (1), 10, 2021 | 27 | 2021 |
| Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1, 2, 3, 6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs M Kondej, TM Wróbel, AG Silva, P Stępnicki, O Koszła, E Kędzierska, ... European Journal of Medicinal Chemistry 180, 673-689, 2019 | 22 | 2019 |
| Multi-targeted drug design strategies for the treatment of schizophrenia P Stępnicki, M Kondej, O Koszła, J Żuk, AA Kaczor Expert opinion on drug discovery 16 (1), 101-114, 2021 | 19 | 2021 |
| What are the challenges with multi-targeted drug design for complex diseases? A Zięba, P Stępnicki, D Matosiuk, AA Kaczor Expert Opinion on Drug Discovery 17 (7), 673-683, 2022 | 15 | 2022 |
| Current approaches and tools used in drug development against parkinson’s disease O Koszła, P Stępnicki, A Zięba, A Grudzińska, D Matosiuk, AA Kaczor Biomolecules 11 (6), 897, 2021 | 12 | 2021 |
| N-(3-{4-[3-(trifluoromethyl) phenyl] piperazin-1-yl} propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a … AA Kaczor, KM Targowska-Duda, P Stępnicki, AG Silva, O Koszła, ... Neurochemistry International 146, 105016, 2021 | 11 | 2021 |
| Multitarget derivatives of D2AAK1 as potential antipsychotics: the effect of substitution in the indole moiety M Kondej, TM Wróbel, KM Targowska‐Duda, A Leandro Martínez, ... ChemMedChem 17 (15), e202200238, 2022 | 5 | 2022 |
| The antipsychotic D2AAK1 as a memory enhancer for treatment of mental and neurodegenerative diseases O Koszła, P Sołek, S Woźniak, E Kędzierska, TM Wróbel, M Kondej, ... International Journal of Molecular Sciences 21 (22), 8849, 2020 | 5 | 2020 |
| Experimental and computational structural studies of 5-substituted-3-(1-Arylmethyl-1, 2, 3, 6-Tetrahydropyridin-4-Yl)-1H-Indoles A Bartyzel, M Kondej, P Stępnicki, TM Wróbel, AA Kaczor Journal of Molecular Structure 1245, 130998, 2021 | 2 | 2021 |
| Effects of small molecules on neurogenesis: Neuronal proliferation and differentiation MK Jastrzębski, P Wójcik, P Stępnicki, AA Kaczor Acta Pharmaceutica Sinica B, 2023 | 1 | 2023 |
| Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents–Design, synthesis, structural studies and pharmacological profiling P Stępnicki, KM Targowska-Duda, AL Martínez, A Zięba, ... European Journal of Medicinal Chemistry 252, 115285, 2023 | 1 | 2023 |
| Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes D Bartuzi, E Kędzierska, KM Targowska-Duda, O Koszła, TM Wróbel, ... Scientific Reports 12 (1), 21192, 2022 | 1 | 2022 |
| Screening and structure–activity relationship of D2AAK1 derivatives for potential application in the treatment of neurodegenerative diseases O Koszła, P Sołek, P Stępnicki, AA Kaczor Molecules 27 (7), 2239, 2022 | 1 | 2022 |
| Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening A Zięba, D Bartuzi, P Stępnicki, D Matosiuk, TM Wróbel, T Laitinen, ... ChemMedChem, e202400080, 2024 | | 2024 |
| Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and … P Stępnicki, O Wronikowska-Denysiuk, A Zięba, KM Targowska-Duda, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2209828, 2023 | | 2023 |
| Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia P Stępnicki, S Wośko, A Bartyzel, A Zięba, D Bartuzi, K Szałaj, TM Wróbel, ... Molecules 28 (10), 4211, 2023 | | 2023 |
